These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12555750)

  • 1. [Transfusion of fresh coagulated plasma: products, indications. General methods and recommendations].
    Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS)
    Transfus Clin Biol; 2002; 9(5-6):322-32. PubMed ID: 12555750
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evolution of neonatal transfusion practices: current recommendations].
    Plaisant F
    Transfus Clin Biol; 2011 Apr; 18(2):262-8. PubMed ID: 21440478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood component therapy.
    Verma A; Hemlata
    Indian J Pediatr; 2008 Jul; 75(7):717-22. PubMed ID: 18716742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fresh Frozen Plasma Administration in the Neonatal Intensive Care Unit: Evidence-Based Guidelines.
    Motta M; Del Vecchio A; Chirico G
    Clin Perinatol; 2015 Sep; 42(3):639-50. PubMed ID: 26250923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indications for labile blood products].
    Jeanne M; Rasonglès P
    Rev Prat; 2001 Jun; 51(12):1318-27. PubMed ID: 11503505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Are the indications and choice of labile blood products adapted? National survey on prescriber's knowledge].
    Rieux C; Bastuji-Garin S; Vicariot M; Chenais F; Courtois F; Waller C; Quaranta JF; Bierling P;
    Presse Med; 2003 Sep; 32(29):1352-8. PubMed ID: 14534496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in QA of leucodepleted blood component and current standard(s). Challenges in quality assurance of leukoreduced components.
    Dumont LJ
    Transfus Sci; 1998 Dec; 19(4):377-80. PubMed ID: 10351162
    [No Abstract]   [Full Text] [Related]  

  • 8. The potential usefulness of thrombelastography in quality monitoring and quality improvement of blood components.
    Seghatchian J
    Transfus Apher Sci; 2009 Dec; 41(3):227-8. PubMed ID: 19800846
    [No Abstract]   [Full Text] [Related]  

  • 9. [Labile blood products and their preparation].
    Chabanel A; Folléa G
    Rev Prat; 2001 Jun; 51(12):1306-10. PubMed ID: 11503503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Techniques of preparation and indications of labile blood products].
    Clément S
    Transfus Clin Biol; 2011 Apr; 18(2):250-61. PubMed ID: 21474355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operational and research approaches to universal leucodepletion in Scotland.
    Prowse C
    Transfus Sci; 1998 Dec; 19(4):367-9. PubMed ID: 10351158
    [No Abstract]   [Full Text] [Related]  

  • 12. French evaluation of conditions for the systematic implementation of leucocyte removal in labile blood products (LBP).
    Chamfly V
    Transfus Sci; 1998 Dec; 19(4):333-42. PubMed ID: 10351148
    [No Abstract]   [Full Text] [Related]  

  • 13. International views on universal leucodepletion: the perspective in NBS, England.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):347-8. PubMed ID: 10351150
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidelines for the use of fresh frozen plasma.
    De Backer D; Vandekerckhove B; Stanworth S; Williamson L; Hermans C; Van der Linden P; Hübner R; Baele P; Jochmans K; Ferrant A; Lambermont M; Muylle L; Toungouz M
    Acta Clin Belg; 2008; 63(6):381-90. PubMed ID: 19170354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical aspects of the self-assessment of the issue and administration of blood: a review of two hospitals' experiences.
    Shulman IA; Jones FS
    Am J Clin Pathol; 1997 Apr; 107(4 Suppl 1):S17-22. PubMed ID: 9124224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children.
    Stanworth SJ; Grant-Casey J; Lowe D; Laffan M; New H; Murphy MF; Allard S
    Transfusion; 2011 Jan; 51(1):62-70. PubMed ID: 20804532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance of blood components prepared in the blood transfusion center/blood bank.
    Vox Sang; 1994; 67(1):99-111. PubMed ID: 7975467
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quality assurance management system for therapy with blood and blood products].
    Diekamp U
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):664-5. PubMed ID: 9825053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quality indicators and dashboards: the experience of a collection department].
    Danic B; Bécel C; Beauplet A
    Transfus Clin Biol; 2000 Apr; 7(2):189-97. PubMed ID: 10812662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety of plasma products may be improved].
    Wahlberg T
    Lakartidningen; 1995 Dec; 92(51-52):4869-70. PubMed ID: 8544500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.